1 / 4

Genomic Biomarker Market: Industry Growth, Market Size, Share and Forecast 2018-2023

The global genomic biomarkers market size was estimated to USD 3,610 million in 2018 and expected to grow at a significant CAGR of 15.6% during the forecast period. Genomic biomarkers is a field of science that is mainly focused on the structure, evolution, function and mapping of genomes.

larebomrglobal
Download Presentation

Genomic Biomarker Market: Industry Growth, Market Size, Share and Forecast 2018-2023

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Orion Market Research Genomic Biomarker Market: Industry Growth, Size, Share and Forecast 2019-2025 Request a free sample of our report on Genomic Biomarker Market - Industry Size, Global Trends, Competitive Analysis and Forecast, 2018-2023 sample/genomic-biomarkers-market ------------------------------------------------------------------------------------ https://www.omrglobal.com/request- Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 7803040404

  2. The global genomic biomarker market is projected to grow at a CAGR of 15.6% during the forecast period (2018-2023). Primarily, genomic biomarkers market is driven by the rising prevalence of various chronic diseases such as cancer, cardiovascular diseases (CVD), and neurological diseases. These biomarkers have been designed to expand its potential in clinical cancer genomics. The cancer genomes study exposes abnormalities in genes and develops different types of cancer. This includes prostate cancer, breast cancer, lung & bronchus cancer, melanoma, thyroid cancer, leukemia, liver cancer, and skin cancer. Additionally, increasing investment and research in genomic biomarkers are also significantly driving the global genomic biomarker market. A full report description of "Genomic Biomarker Market - Global Trends, Size, Share, Growth, Industry Analysis and Forecast, 2018-2023" at https://www.omrglobal.com/industry-reports/genomic- biomarkers-market Due to advantages of genomic biomarkers in diagnosis, the research has been further supported by the investments. A large number of biomarkers have been developed till now in the global genomic biomarker industry. For instance, according to Genome Research, there are 106 separate biomarkers developed for breast cancer for different accuracy, specific clinical or molecular characteristics, number of genes, ease of interpretation, and biological origin as of 2014. In order to increase the accuracy further for clinical applications, governments are investing in research facilities. The National Cancer Institute (NCI) in March 2016 had earmarked $5.5 million for funding for the establishment of laboratories with an aim to advance research on biomarkers and biomarker assays for various cancers such as of the prostate, lung, breast, and genitourinary organs. To learn more about this report request a free sample copy @ https://www.omrglobal.com/request- sample/genomic-biomarkers-market The Biomarker Developmental Laboratories (BDLs) will be a part of the early detection research network of the NCI. Within this funding the NCI’s aim is to fund eight to ten BDLs that will be involved in developing and characterizing the new biomarkers and assays or refining the existing ones. The research areas included in this funding opportunity are the development of new serum- and tissue-related biomarkers for detection and diagnosis of cancer; discovery and development of promising omics biomarkers; and the integration of cell signalling, genetic, and biochemical pathways into novel network- and pathway-based biomarkers with a wider applicability across different tumor types. The development and research process in biomarkers include internal validation. There are two types of validation that takes places to review the accuracy and reliability of the biomarker test. Analytical and clinical validation are the two main validations. The analytical validation displays the accuracy and reliability of the test. While, clinical validation represents robust and reliable results for the test. The continuous interest of the government and big companies in the research and development of new technologies for biomarker is a driver that is motivating the market growth for global genomic biomarkers market.

  3. Visit here to know more about Global Genomic Biomarker Market Global Genomic Biomarker Market – Segment By Disease Indication •Oncology •Cardiology •Neurology •Others By End-User •Hospitals •Diagnostics Centers and Research Laboratories Global Genomic Biomarker Market – Regional North America •US •Canada Europe •Germany •UK •France •Spain •Italy •Rest of Europe Asia-Pacific •China •Japan •India •Rest of Asia-Pacific Rest of the World

  4. About Orion Market Research Orion Market Research (OMR) is an Indian market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. For More Information, Visit Orion Market Research Media Contact: Company Name: Orion Market Research Contact Person: Mr. AnuragTiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 780-304-0404 Source: Global Genomic Biomarker Market

More Related